{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T05:04:31Z","timestamp":1764997471531,"version":"build-2065373602"},"reference-count":57,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.jacl.2022.06.001","type":"journal-article","created":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T03:43:02Z","timestamp":1655437382000},"page":"423-433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["A novel homozygous frameshift mutation in the APOA1 gene associated with marked high-density lipoprotein deficiency"],"prefix":"10.1016","volume":"16","author":[{"given":"Tadashi","family":"Takeda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsubasa","family":"Ide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daishi","family":"Okuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1693-3177","authenticated-orcid":false,"given":"Masayuki","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakiyo","family":"Asada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika","family":"Kirinashizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misato","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junko","family":"Miyoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koutaro","family":"Yokote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohiro","family":"Mizutani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2022.06.001_bib0001","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1093\/eurheartj\/ehx163","article-title":"Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: Two prospective cohort studies","volume":"38","author":"Madsen","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2022.06.001_bib0002","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ijcard.2018.11.095","article-title":"Associations between risk of overall mortality, cause-specific mortality and level of inflammatory factors with extremely low and high high-density lipoprotein cholesterol levels among American adults","volume":"276","author":"Mazidi","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacl.2022.06.001_bib0003","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1016\/S0022-2275(20)37453-8","article-title":"Apolipoprotein-mediated removal of cellular cholesterol and phospholipids","volume":"37","author":"Oram","year":"1997","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2022.06.001_bib0004","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1161\/CIRCULATIONAHA.111.066589","article-title":"Cholesterol efflux and atheroprotection: Advancing the concept of reverse cholesterol transport","volume":"125","author":"Rosenson","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2022.06.001_bib0005","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nri3520","article-title":"Macrophages in Atherosclerosis: a dynamic balance","volume":"13","author":"Moore","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jacl.2022.06.001_bib0006","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.molmed.2011.05.013","article-title":"Biological activities of HDL subpopulations and their relevance to cardiovascular disease","volume":"17","author":"Camont","year":"2011","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.jacl.2022.06.001_bib0007","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12944-017-0604-5","article-title":"High-density lipoprotein cholesterol efflux capacity is inversely associated with cardiovascular risk: A systematic review and meta-analysis","volume":"16","author":"Qiu","year":"2017","journal-title":"Lipid Health Dis"},{"key":"10.1016\/j.jacl.2022.06.001_bib0008","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0022-2275(20)39898-9","article-title":"Molecular physiology of reverse cholesterol transport","volume":"36","author":"Fielding","year":"1995","journal-title":"J Lipid Res"},{"issue":"6","key":"10.1016\/j.jacl.2022.06.001_bib0009","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0022-2275(20)32028-9","article-title":"Apolipoprotein A-I: structure-function relationships","volume":"41","author":"Frank","year":"2000","journal-title":"J Lipid Res"},{"issue":"1-2","key":"10.1016\/j.jacl.2022.06.001_bib0010","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S1388-1981(01)00081-6","article-title":"Structural models of human apolipoprotein A-I: a critical analysis and review","volume":"1531","author":"Brouillette","year":"2001","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jacl.2022.06.001_bib0011","doi-asserted-by":"crossref","first-page":"23227","DOI":"10.1074\/jbc.M303365200","article-title":"Domain structure and lipid interaction in human apolipoproteins A-I and E, a general model","volume":"278","author":"Saito","year":"2003","journal-title":"J. Biol Chem"},{"issue":"4","key":"10.1016\/j.jacl.2022.06.001_bib0012","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.plipres.2004.05.002","article-title":"Contributions of domain structure and lipid interaction to the functionality of exchangeable human apolipoproteins","volume":"43","author":"Saito","year":"2004","journal-title":"Prog Lipid Res"},{"issue":"6","key":"10.1016\/j.jacl.2022.06.001_bib0013","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nsb931","article-title":"The C-terminal domain of apolipoprotein A-I contains a lipid-sensitive conformational trigger","volume":"10","author":"Oda","year":"2003","journal-title":"Nat Struct Biol"},{"key":"10.1016\/j.jacl.2022.06.001_bib0014","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nsmb1284","article-title":"The refined structure of nascent HDL reveals a key functional domain for particle maturation and dysfunction","volume":"14","author":"Wu","year":"2007","journal-title":"Nat Struct Mol Biol"},{"issue":"291","key":"10.1016\/j.jacl.2022.06.001_bib0015","doi-asserted-by":"crossref","first-page":"6386","DOI":"10.1074\/jbc.M115.696088","article-title":"A Systematic Investigation of Structure\/Function Requirements for the Apolipoprotein A-I\/Lecithin Cholesterol Acyltransferase Interaction Loop of High-density Lipoprotein","volume":"18","author":"Gu","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jacl.2022.06.001_bib0016","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.atherosclerosis.2005.10.033","article-title":"Differential diagnosis of familial high density lipoprotein deficiency syndromes","volume":"186","author":"Eckardstein","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2022.06.001_bib0017","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0021-9150(01)00724-9","article-title":"Apolipoprotein A-I deficiency with accumulated risk for CHD but no symptoms of CHD","volume":"162","author":"Yokota","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2022.06.001_bib0018","unstructured":"https:\/\/www.jsum.or.jp\/committee\/diagnostic\/pdf\/jsum0515_guideline.pdf 2022"},{"key":"10.1016\/j.jacl.2022.06.001_bib0019","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/S0022-2275(20)38610-7","article-title":"New substrate for determination of serum lecithin:cholesterol acyltransferase","volume":"28","author":"Manabe","year":"1987","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2022.06.001_bib0020","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0009-8981(77)90355-2","article-title":"A new colorimetric method for the determination of plasma lecithin-cholesterol acyltransferase activity","volume":"75","author":"Nagasaki","year":"1977","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jacl.2022.06.001_bib0021","first-page":"1","article-title":"Ceiling culture-derived proliferative adipocytes are a possible delivery vehicle in enzyme replacement therapy in lecithin:cholesterol acyltransferase deficiency. The Open Gene Ther","volume":"4","author":"Kuroda","year":"2011","journal-title":"J."},{"key":"10.1016\/j.jacl.2022.06.001_bib0022","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1161\/01.ATV.0000155017.60171.88","article-title":"Identification of unique lipoprotein subclasses for visceral obesity by component analysis of cholesterol profile in high-performance liquid chromatography","volume":"25","author":"Okazaki","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2022.06.001_bib0023","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0022-2275(20)30123-1","article-title":"A new on-line dual enzymatic method for simultaneous quantification of cholesterol and triglycerides in lipoproteins by HPLC","volume":"43","author":"Usui","year":"2002","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2022.06.001_bib0024","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1161\/ATVBAHA.114.303420","article-title":"Lipoprotein subfractions highly associated with renal damage in familial LCAT deficiency","volume":"34","author":"Kuroda","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2022.06.001_bib0025","doi-asserted-by":"crossref","first-page":"802","DOI":"10.5551\/jat.RV17053","article-title":"Current Diagnosis and Management of Tangier Disease","volume":"28","author":"Koseki","year":"2021","journal-title":"J Atheroscler Thromb"},{"issue":"452","key":"10.1016\/j.jacl.2022.06.001_bib0026","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cca.2015.11.021","article-title":"Subfraction analysis of circulating lipoproteins in a patient with Tangier disease due to a novel ABCA1 mutation","volume":"15","author":"Murano","year":"2016","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jacl.2022.06.001_bib0027","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0022-2275(20)37433-2","article-title":"The molecular pathology of lecithin:cholesterol acyltransferase (LCAT) deficiency syndromes","volume":"38","author":"Kuivenhoven","year":"1997","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2022.06.001_bib0028","doi-asserted-by":"crossref","first-page":"679","DOI":"10.5551\/jat.RV17051","article-title":"Harada-Shiba M. Current Status of Familial LCAT Deficiency in Japan","volume":"28","author":"Kuroda","year":"2021","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.jacl.2022.06.001_bib0029","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1172\/JCI109956","article-title":"A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family","volume":"66","author":"Franceschini","year":"1980","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacl.2022.06.001_bib0030","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJM198206243062503","article-title":"Familial deficiency of apolipoprotein A-I and C-III and precocious coronary-artery disease","volume":"306","author":"Norum","year":"1982","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jacl.2022.06.001_bib0031","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1161\/01.ATV.2.1.16","article-title":"Plasma apolipoprotein A-I absence associated with a marked reduction of high density lipoproteins and premature coronary artery disease","volume":"2","author":"Schaefer","year":"1982","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.jacl.2022.06.001_bib0032","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1073\/pnas.88.7.2793","article-title":"Apolipoprotein A-I deficiency due to a codon 84 nonsense mutation of the apolipoprotein A-I gene","volume":"88","author":"Matsunaga","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jacl.2022.06.001_bib0033","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/clc.4960090709","article-title":"Deficiency of apolipoprotein A and C-III and severe coronary heart disease","volume":"9","author":"Hiasa","year":"1986","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacl.2022.06.001_bib0034","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1172\/JCI114997","article-title":"A frameshift mutation in the human apolipoprotein A-I gene causes high density lipoprotein deficiency, partial lecithin: cholesterol-acyltransferase deficiency, and. corneal opacities","volume":"87","author":"Funke","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacl.2022.06.001_bib0035","doi-asserted-by":"crossref","first-page":"13654","DOI":"10.1016\/S0021-9258(18)92750-X","article-title":"A mutation in the human apolipoprotein A-I gene. Dominant effect on the level and characteristics of plasma high density lipoproteins","volume":"266","author":"Deeb","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jacl.2022.06.001_bib0036","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1172\/JCI116830","article-title":"High density lipoprotein deficiency with xanthomas: a defect in reverse cholesterol transport caused by a point mutation in the apolipoprotein A-I gene","volume":"92","author":"Lackner","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacl.2022.06.001_bib0037","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1172\/JCI116949","article-title":"Apolipoprotein A-I Q[\u22122]X causing isolated apolipoprotein A-I deficiency in a family with analphalipoproteinemia","volume":"93","author":"Ng","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacl.2022.06.001_bib0038","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1161\/01.ATV.15.12.2157","article-title":"Apolipoprotein A-I deficiency. Biochemical and metabolic characteristics","volume":"15","author":"Ng","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2022.06.001_bib0039","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1161\/01.ATV.14.12.1915","article-title":"A nonsense mutation in the apolipoprotein A-I gene is associated with high-density lipoprotein deficiency and periorbital xanthelasmas","volume":"14","author":"Romling","year":"1994","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.jacl.2022.06.001_bib0040","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1161\/01.ATV.15.11.1866","article-title":"A new case of apoA-I deficiency showing codon 8 nonsense mutation of the apoA-I gene without evidence of coronary heart disease","volume":"15","author":"Takaka","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2022.06.001_bib0041","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1161\/01.ATV.16.12.1416","article-title":"A cysteine-containing truncated apo A-I variant associated with HDL deficiency","volume":"16","author":"Moriyama","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2022.06.001_bib0042","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1161\/01.CIR.94.7.1622","article-title":"Compound heterozygosity for a structural apolipoprotein A-I variant, apo A-I(L141R)Pisa, and an apolipoprotein A-I null allele in patients with absence of HDL cholesterol, corneal opacifications, and coronary heart disease","volume":"94","author":"Miccoli","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2022.06.001_bib0043","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1161\/01.ATV.17.11.3021","article-title":"Apolipoprotein A-IFIN (Leu159\u2013>Arg) mutation affects lecithin cholesterol acyltransferase activation and subclass distribution of HDL but not cholesterol efflux from fibroblasts","volume":"17","author":"Miettinen","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2022.06.001_bib0044","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0022-2275(20)37281-3","article-title":"Heterozygosity for apolipoprotein A-I(R160L) Oslo is associated with low levels of high density lipoprotein cholesterol and HDL-subclass LpA-I\/A-II but normal levels of HDL-subclass LpA-I","volume":"38","author":"Leren","year":"1997","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2022.06.001_bib0045","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1161\/01.ATV.18.3.389","article-title":"A novel homozygous missense mutation in the apo A-I gene with apo A-I deficiency","volume":"18","author":"Huang","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2022.06.001_bib0046","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1161\/01.ATV.18.8.1242","article-title":"Apolipoprotein A-I(Zavalla) (Leu159\u2013>Pro): HDL cholesterol deficiency in a kindred associated with premature coronary artery disease","volume":"18","author":"Miller","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2022.06.001_bib0047","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1161\/01.ATV.19.2.348","article-title":"Compound heterozygosity for an apolipoprotein A1 gene promoter mutation and a structural nonsense mutation with apolipoprotein A1 deficiency","volume":"19","author":"Matsunaga","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2022.06.001_bib0048","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0022-2275(20)30194-2","article-title":"ApoA-I(MALLORCA) impairs LCAT activation and induces dominant familial hypoalphalipoproteinemia","volume":"43","author":"Mart\u00edn-Campos","year":"2002","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2022.06.001_bib0049","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.atherosclerosis.2003.09.024","article-title":"A novel two nucleotide deletion in the apolipoprotein A-I gene, apoA-I Shinbashi, associated with high density lipoprotein deficiency, corneal opacities, planar xanthomas, and premature coronary artery disease","volume":"172","author":"Ikewaki","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2022.06.001_bib0050","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jacl.2015.02.005","article-title":"Case report: A novel apolipoprotein A-I missense mutation apoA-I (Arg149Ser)Boston associated with decreased lecithin-cholesterol acyltransferase activation and cellular cholesterol efflux","volume":"9","author":"Anthanont","year":"2015","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2022.06.001_bib0051","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jacl.2017.12.012","article-title":"A case of apolipoprotein A-I deficiency due to carboxyl-terminal truncation","volume":"12","author":"Tanaka","year":"2018","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2022.06.001_bib0052","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00041433-199606000-00002","article-title":"Unravelling high density lipoprotein-apolipoprotein metabolism in human mutants and animal models","volume":"7","author":"Rader","year":"1996","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jacl.2022.06.001_bib0053","doi-asserted-by":"crossref","first-page":"119","DOI":"10.5551\/jat.32854","article-title":"Role of LCAT in Atherosclerosis","volume":"23","author":"Ossoli","year":"2016","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.jacl.2022.06.001_bib0054","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1172\/JCI111576","article-title":"Familial apolipoprotein AI and apolipoprotein CIII deficiency: subclass distribution, composition, and morphology of lipoproteins in a disorder associated with premature atherosclerosis","volume":"74","author":"Forte","year":"1984","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacl.2022.06.001_bib0055","doi-asserted-by":"crossref","first-page":"7198","DOI":"10.1073\/pnas.84.20.7198","article-title":"DNA inversion within the apolipoproteins AI\/CIII\/AIV-encoding gene cluster of certain patients with premature atherosclerosis","volume":"84","author":"Karathanasis","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jacl.2022.06.001_bib0056","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0022-2275(20)34282-6","article-title":"Familial apolipoprotein A-I and C-III deficiency, variant II","volume":"26","author":"Schaefer","year":"1985","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2022.06.001_bib0057","doi-asserted-by":"crossref","first-page":"16339","DOI":"10.1016\/S0021-9258(19)84708-7","article-title":"Familial apolipoprotein A-I, C-III, and A-IV deficiency and premature atherosclerosis due to deletion of a gene complex on chromosome 11","volume":"264","author":"Ordovas","year":"1989","journal-title":"J Biol Chem"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287422001751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287422001751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:37:35Z","timestamp":1761831455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287422001751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S1933287422001751"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2022.06.001","relation":{},"ISSN":["1933-2874"],"issn-type":[{"type":"print","value":"1933-2874"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel homozygous frameshift mutation in the APOA1 gene associated with marked high-density lipoprotein deficiency","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2022.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 National Lipid Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}